NDC 71894-110 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-110
- Package NDCs from labels
- 71894-110-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pocket Nurse | ISOPROPYL ALCOHOL | Pocket Nurse Enterprises, LLC | 42ded32e-15d9-8b03-e063-6394a90ad6bc | 2025-11-06 | Warnings | 797544 ND2M416302 |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | d3d29c8f-c326-4097-814a-7f4e08c67068 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | 01721071-af03-4894-95c1-10b8bc64b888 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | f6d82772-638c-4584-b9d3-8833669f5963 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| ChloraPrep One-Step | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | CareFusion 213, LLC | 85291b2b-40b9-07fa-e053-2a91aa0a84e4 | 2025-11-04 | Warnings | ND2M416302 |
| Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, SULPHUR | TRP Company | 42b6b9b9-a673-0bba-e063-6394a90a8866 | 2025-11-03 | Warnings | 451W47IQ8X |
| ChloraPrep One-Step | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | CareFusion 213, LLC | 85416361-90b5-3efa-e053-2a91aa0af431 | 2025-11-03 | Warnings | ND2M416302 |
| ChloraPrep One-Step | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | CareFusion 213, LLC | 8528a4f5-5ff4-45f3-e053-2991aa0a804c | 2025-11-03 | Warnings | ND2M416302 |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | ICU Medical Inc. | d8ee14e9-6733-4813-9f21-2b043a5f7188 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | ICU Medical Inc. | 4555b1bf-6d97-4798-a63d-6d34291c85ce | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | ICU Medical Inc. | 9dd1c001-73b3-41d4-9a96-61f6ad3a5dc3 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 3cfdeee0-ff14-4341-8396-b11c2a037c60 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 5f372b75-d7a4-471e-8ac6-290040fc84b0 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | ICU Medical Inc. | 243fe8fc-996a-4855-8daf-069628e547c4 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | ICU Medical Inc. | d310d170-5eeb-471b-af1a-0e845001d21d | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Simlandi | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 12f609c9-2088-bb05-e063-6394a90a9ecc | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 797544 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.